论文部分内容阅读
拜糖平是世界上第一个a－糖苦酶抑制剂，本院自1995年4月至11月，将此药与胰岛素合用治疗30例胰岛素依赖型糖尿病（IDDM）患者，现报告如下：1临床资料1．1一般资料按世界卫生组织（WHO）标准确诊的IDDM30例，为本院同期的门诊和住院患者，其中男性12例，女性18例；年龄27～38
Aspirin is the world’s first a-glucotoxin inhibitor, our hospital from April 1995 to November, the drug combined with insulin treatment of 30 patients with insulin-dependent diabetes (IDDM), are reported as follows: 1 Clinical data 1.1 General information According to the World Health Organization (WHO) confirmed IDDM30 cases, the same period for the outpatient and inpatient hospital, including 12 males and 18 females; aged from 27 to 38